Karyopharm Therapeutics Inc. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Karyopharm Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Karyopharm Therapeutics Inc. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22 2021 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Sell | S | 14.83 | 1,186 | 17,590 | 51,791 | 53 K to 51.8 K (-2.24 %) |
| Feb 22 2021 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, Chief Dev. Off ... | Sell | S | 14.83 | 2,887 | 42,818 | 46,126 | 49 K to 46.1 K (-5.89 %) |
| Feb 22 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 14.83 | 9,495 | 140,822 | 575,126 | 584.6 K to 575.1 K (-1.62 %) |
| Feb 22 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 14.83 | 9,495 | 140,822 | 776,452 | 785.9 K to 776.5 K (-1.21 %) |
| Feb 22 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.83 | 9,495 | 140,822 | 776,452 | 785.9 K to 776.5 K (-1.21 %) |
| Feb 22 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.83 | 9,495 | 140,822 | 575,126 | 584.6 K to 575.1 K (-1.62 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP, Chief Reg. Aff ... | Option Exercise | M | 0.00 | 5,650 | 0 | 16,950 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP, Chief Reg. Aff ... | Buy | M | 0.00 | 5,650 | 0 | 6,189 | 539 to 6.2 K (+1,048.24 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, Chief Dev. Off ... | Option Exercise | M | 0.00 | 5,650 | 0 | 16,950 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, Chief Dev. Off ... | Buy | M | 0.00 | 5,650 | 0 | 41,384 | 35.7 K to 41.4 K (+15.81 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Mason Michael | SVP, CFO & Treasure ... | Option Exercise | M | 0.00 | 8,150 | 0 | 24,450 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Mason Michael | SVP, CFO & Treasure ... | Buy | M | 0.00 | 8,150 | 0 | 8,150 | 0 to 8.2 K |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.00 | 14,300 | 0 | 42,900 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.00 | 14,300 | 0 | 42,900 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.00 | 14,300 | 0 | 569,422 | 555.1 K to 569.4 K (+2.58 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.00 | 14,300 | 0 | 770,789 | 756.5 K to 770.8 K (+1.89 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.00 | 14,300 | 0 | 42,900 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.00 | 14,300 | 0 | 42,900 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.00 | 14,300 | 0 | 770,789 | 756.5 K to 770.8 K (+1.89 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.00 | 14,300 | 0 | 569,422 | 555.1 K to 569.4 K (+2.58 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Option Exercise | M | 0.00 | 5,650 | 0 | 16,950 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Buy | M | 0.00 | 5,650 | 0 | 49,875 | 44.2 K to 49.9 K (+12.78 %) |